K. Punt

1.4k total citations
28 papers, 489 citations indexed

About

K. Punt is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, K. Punt has authored 28 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Genetics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in K. Punt's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Iron Metabolism and Disorders (5 papers). K. Punt is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and Iron Metabolism and Disorders (5 papers). K. Punt collaborates with scholars based in Netherlands, South Africa and Germany. K. Punt's co-authors include A. W. Dekker, H. C. van Prooijen, Titus H.J. Huisman, M. Boogaerts, M. Peetermans, R. L. Verwilghen, R. De Bock, Guido Tricot, M. C. Verloop and J. de Wael and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

K. Punt

26 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Punt Netherlands 11 293 149 112 106 83 28 489
M Sakurai Japan 12 192 0.7× 57 0.4× 112 1.0× 129 1.2× 38 0.5× 34 447
Matthew Ming Kong Shing Hong Kong 14 194 0.7× 95 0.6× 84 0.8× 171 1.6× 97 1.2× 32 515
L Markling Sweden 13 310 1.1× 148 1.0× 63 0.6× 72 0.7× 53 0.6× 28 616
AD Hess United States 11 376 1.3× 52 0.3× 54 0.5× 53 0.5× 76 0.9× 16 554
Rosemary E. Millard United Kingdom 14 207 0.7× 218 1.5× 26 0.2× 101 1.0× 76 0.9× 24 483
GR Buchanan United States 12 410 1.4× 144 1.0× 373 3.3× 164 1.5× 80 1.0× 15 710
S. K. China 11 176 0.6× 61 0.4× 105 0.9× 85 0.8× 46 0.6× 23 337
C. Pearson United Kingdom 12 194 0.7× 86 0.6× 186 1.7× 104 1.0× 93 1.1× 22 595
D G Nathan United States 10 249 0.8× 118 0.8× 20 0.2× 152 1.4× 75 0.9× 17 505
I. Yaniv Israel 14 125 0.4× 74 0.5× 102 0.9× 122 1.2× 48 0.6× 29 471

Countries citing papers authored by K. Punt

Since Specialization
Citations

This map shows the geographic impact of K. Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Punt more than expected).

Fields of papers citing papers by K. Punt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Punt. The network helps show where K. Punt may publish in the future.

Co-authorship network of co-authors of K. Punt

This figure shows the co-authorship network connecting the top 25 collaborators of K. Punt. A scholar is included among the top collaborators of K. Punt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Punt. K. Punt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Centanni, Maddalena, Afroditi Nanou, Leon W.M.M. Terstappen, et al.. (2025). Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer. Clinical Pharmacology & Therapeutics. 119(2). 403–413.
2.
Kweekel, Dina M., Hans Gelderblom, Miriam Koopman, et al.. (2013). Concordance of Genotype for Polymorphisms in DNA Isolated from Peripheral Blood and Colorectal Cancer Tumor Samples. Pharmacogenomics. 14(16). 2005–2012. 22 indexed citations
3.
Buyse, Marc, K. Punt, C.-H. Köhne, et al.. (2007). Endpoints in adjuvant trials: A systematic review of the literature in colon cancer and proposed definitions for future trials. Journal of Clinical Oncology. 25(18_suppl). 4018–4018. 2 indexed citations
4.
Cloete, S.W.P., et al.. (2001). Factors related to high levels of ostrich chick mortality from hatching to 90 days of age in an intensive rearing system. Journal of the South African Veterinary Association. 72(4). 197–202. 31 indexed citations
5.
Cloete, S.W.P., et al.. (2000). The effect of pre-slaughter stress resulting from feed withdrawal on meat quality characteristics in ostriches. South African Journal of Animal Science. 30(4). 3 indexed citations
6.
7.
Dekker, A. W., K. Punt, & Leo F. Verdonck. (1987). The Use of Amsacrine plus Intermediate-Dose Cytosine Arabinoside in Relapsed and Refractory Acute Nonlymphocytic Leukemia. Hämatologie und Bluttransfusion. 30. 333–335. 2 indexed citations
8.
Prooijen, H. C. van, Petra Muus, J. M. M. Roelofs, & K. Punt. (1986). Does the metabolite uracil arabinoside inhibit cytosine arabinoside (Ara‐C) penetration into the cerebrospinal fluid during high‐dose Ara‐C therapy?. Scandinavian Journal of Haematology. 36(1). 123–126. 6 indexed citations
9.
10.
Prooijen, H. C. van, K. Punt, & Petra Muus. (1985). CEREBROSPINAL FLUID CONCENTRATIONS OF CYTOSINE ARABINOSIDE DURING INTRAVENOUS THERAPY WITH INTERMEDIATE DOSE: A PRELIMINARY REPORT. British Journal of Haematology. 59(1). 188–190. 5 indexed citations
11.
Jansen, Gerrit, Leo Koenderman, Gert Rijksen, et al.. (1985). Age dependent behaviour of red cell glycolytic enzymes in haematological disorders. British Journal of Haematology. 61(1). 51–59. 5 indexed citations
12.
Dekker, A W, A. Elderson, K. Punt, & J J Sixma. (1985). Meningeal involvement in patients with acute nonlymphocytic leukemia incidence, management, and predictive factors. Cancer. 56(8). 2078–2082. 23 indexed citations
13.
Prooijen, H. C. van, A. W. Dekker, & K. Punt. (1984). The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse. British Journal of Haematology. 57(2). 291–299. 1 indexed citations
14.
Tricot, Guido, R. De Bock, A. W. Dekker, et al.. (1984). Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes. British Journal of Haematology. 58(2). 231–240. 86 indexed citations
15.
Dekker, AW, Sixma Jj, & K. Punt. (1982). The management of acute non-lymphocytic leukaemia in adults. Evaluation of the results in a non-selected group of 114 patients.. PubMed. 25(9). 297–302. 2 indexed citations
16.
Biervliet, J.P. Van, et al.. (1975). PHILADELPHIA CHROMOSOME IN ACUTE LYMPHOCYTIC LEUKÆMIA. The Lancet. 306(7935). 617–617. 26 indexed citations
17.
Verloop, M. C., P. W. Helleman, & K. Punt. (1966). Hypochromic Anaemia without Iron Deficiency. Acta Medica Scandinavica. 179(S445). 249–255. 4 indexed citations
18.
Helleman, P. W., K. Punt, & M. C. Verloop. (1964). Occurrence of Hæmoglobin H and Hæmoglobin Bart's in Alpha-thalassæmia: a Family with Two Possible Homozygous Cases and with G-6-PD-deficiency. Nature. 201(4923). 1039–1040. 2 indexed citations
19.
Huisman, Titus H.J., et al.. (1961). Thalassemia Minor Associated with Hemoglobin-B2 Heterozygosity. A Family Report. Blood. 17(6). 747–757. 51 indexed citations
20.
Punt, K., et al.. (1955). Hemorrhagic disease characterized by a combination of a shortage of anti-hemophilic factor and a vascular disorder in a woman.. PubMed. 24(4). 310–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Sakurai Breakdown of academic impact, for papers by Matthew Ming Kong Shing Breakdown of academic impact, for papers by L Markling Breakdown of academic impact, for papers by AD Hess Breakdown of academic impact, for papers by Rosemary E. Millard Breakdown of academic impact, for papers by GR Buchanan Breakdown of academic impact, for papers by S. K. Breakdown of academic impact, for papers by C. Pearson Breakdown of academic impact, for papers by D G Nathan Breakdown of academic impact, for papers by I. Yaniv
Rankless by CCL
2026